Resource Center: buprenorphine, screening and diagnosis

A comprehensive PDF from CSAM that contains 1) the Drug Abuse Screening Test (DAST-10), 2) the Skinner Trauma History, 3) the CAGE questionnaire, 4) the TWEAK questionnaire, 5) the Alcohol Use Disorder Identification Test (AUDIT), 6) the Michigan Alcoholism Screening Test (MAST), 7) the Self-Administered Short Michigan Alcoholism Screening Test (SMAST), 8) Narcotic Withdrawal Scale, 9) the Clinical Institute Narcotic Assessment (CINA) Scale for Withdrawal, 10) the Clinical Opiate Withdrawal Scale (COWS), 11) the Objective Opiate Withdrawal Scale (OOWS), 12) the Subjective Opiate Withdrawal Scale (SOWS), and 13) the Addiction Research Foundation Clinical Institute for Withdrawal Assessment (CIWA-Ar). (From Their Website)

The American Psychiatric Association has released practice guidelines and resources for the treatment of patients with substance use disorders.

Symptoms, Red Flags, and Risk Factors of Abuse/Dependence informational page

This manual has been prepared by the Drug Enforcement Administration, Office of Diversion Control, to assist practitioners (physicians, dentists, veterinarians, and other registrants authorized to prescribe, dispense, and administer controlled substances) in their understanding of the Federal Controlled Substances Act and its implementing regulations as they pertain to the practitioner’s profession.

The mood disorder questionnaire consists of five yes or no questions to be completed by the patient. The MDQ was developed by a team of psychiatrists, researchers and consumer advocates to address a critical need for timely and accurate diagnosis of bipolar disorder, which can be fatal if left untreated. The questionnaire takes about five minutes to complete, and can provide important insights into diagnosis and treatment.

The ASAM Patient Placement Criteria for the Treatment of Substance-Related Disorders, Second Edition-Revised (Mee-Lee et al., 2001) lists the 5 basic levels of care available for adult substance users. These levels of care range from Early Intervention (for at-risk individuals) to Medically Managed Intensive Inpatient Treatment (for patients with severe disorders who require around-the-clock care). The Patient Placement Criteria classifies opioid maintenance therapy as a Level I treatment since it is most often conducted in outpatient settings.

A site for physicians, researchers, pharmacists, nurses, and counselors to learn more about buprenorphine as a medication for opioid addiction treatment.

This National Institute on Drug Abuse monograph includes helpful information on screening and assessment.

This website provides a list of the most current, top news stories dealing with HIV-HCV coinfection.

Dr. Maillin talks about patients addicted to pain medications.